TWA
ASND icon

TCI Wealth Advisors’s Ascendis Pharma A/S ASND Stock Holding History

TCI Wealth Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-67
Closed -$8.18K – 2525
2022
Q4 		$8.18K Buy
+67
New +$7.78K ﹤0.01% 1215

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCI Wealth Advisors's ASND Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2023, closing a stake of 67 shares — an estimated $8.18K sold.

TCI Wealth Advisors first reported a position in ASND in Q4 2022 and held it in 1 quarter. The position peaked at $8.18K in Q4 2022. 164 funds tracked by Wall St. Rank hold ASND as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 67 Ascendis Pharma A/S shares in Q1 2023, an estimated $8.18K.
  • TCI Wealth Advisors first reported a position in Ascendis Pharma A/S in Q4 2022 and held it in 1 quarter.
  • TCI Wealth Advisors's Ascendis Pharma A/S position peaked at $8.18K in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.